Simcere Pharmaceutical Group Limited | WebDisclosure

Basculer en Français

10032	Companies
204164	Keywords
134538	Articles
108308	Press releases

Headlines Articles Press releases Simcere Pharmaceutical Group Limited

Home
Companies
Simcere Pharmaceutical Group Limited

BRIEF

published on 01/27/2026 at 12:00, 1 month 19 days ago

Boehringer Ingelheim and Simcere Collaborate on IBD Treatment

Immunology Boehringer Ingelheim Inflammatory Bowel Disease Bispecific Antibody Simcere Partnership
BRIEF

published on 01/27/2026 at 12:00, 1 month 19 days ago

Boehringer Ingelheim et Simcere collaborent sur le traitement des MII

Boehringer Ingelheim Immunologie Maladie Inflammatoire De L'intestin Anticorps Bispécifique Partenariat Simcere
PRESS RELEASE

published on 01/27/2026 at 11:55, 1 month 19 days ago

Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment for inflammatory bowel disease. SIM0709, a novel bispecific antibody, aims to improve outcomes for patients worldwide

Boehringer Ingelheim Inflammatory Bowel Disease IBD Simcere Antibody Treatment

Accesswire

Published on 03/15/2026 at 23:25, 8 hours 22 minutes ago

Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 13 hours 47 minutes ago

SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 8 hours ago

CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 8 hours ago

Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 10 hours ago

Alset AI Announces Closing of Shares for Debt Transaction

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 07:30, 17 minutes ago

Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group revenues and Holding’s net income in the fiscal year 2025 – medium-term targets raised to 25%...
Published on 03/16/2026 at 07:24, 22 minutes ago

EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026
Published on 03/16/2026 at 07:05, 42 minutes ago

Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025
Published on 03/16/2026 at 07:02, 45 minutes ago

Changes to the Board of Directors of Julius Baer Group
Published on 03/16/2026 at 07:00, 47 minutes ago

BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start

Les Echos

Published on 03/13/2026 at 20:30, 2 days 11 hours ago

ALTAREA : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025
Published on 03/13/2026 at 20:30, 2 days 11 hours ago

ALTAREIT : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025
Published on 03/13/2026 at 19:50, 2 days 11 hours ago

Modalités de mise à disposition du Document d’Enregistrement Universel 2025 d’ENGIE
Published on 03/13/2026 at 19:50, 2 days 11 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 13 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE

View all LES ECHOS COMFI WIRE